Anixa Biosciences (ANIX)

• Market cap: $105M
• 1 day: -0.63%
• 5 days: -3.93%
• 1 month: -27.73%
• 3 months: -6.74%
• 6 months: -3.64%
• Year to date: 34.18%
• 1 year: 27.2%
• 5 years: 8.9%
• 10 years: 24.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Employees: 5